Chin‐Tung Chen
Impact in
- Hepatology top 5%
- Liver physiology and pathology
- Hepatocellular Carcinoma Treatment and Prognosis
- Oncology top 5%
- Colorectal Cancer Treatments and Studies
- Cutaneous Melanoma Detection and Management
- HER2/EGFR in Cancer Research
Papers in
- Oncology 10
- Colorectal Cancer Treatments and Studies 5
- Colorectal Cancer Screening and Detection 3
-
- PI3K/AKT/mTOR signaling in cancer 3
- Co-authors
- Martin R. Weiser (16 shared papers)James G. Christensen (4 shared papers)David Liska (3 shared papers)Thomas Bachleitner‐Hofmann (3 shared papers)Philip B. Paty (3 shared papers)Zhaoshi Zeng (4 shared papers)Mark Gimbel (2 shared papers)Sizhi Paul Gao (1 shared paper)
- Journals
- Molecular Cancer Therapeutics (3 papers)Clinical Cancer Research (2 papers)Journal of Clinical Oncology (2 papers)Cancer Research (2 papers)International Journal of Radiation Oncology*Biology*Physics (1 paper)
- Partner nations
- United StatesItalyGermany
In The Last Decade
Chin‐Tung Chen
22 papers receiving 971 citations
Peers
Comparison fields: 5 of 57
- Hepatology 250
- Oncology 574
- Gastroenterology 66
- Pathology and Forensic Medicine 184
- Cancer Research 152
Countries citing papers authored by Chin‐Tung Chen
This map shows the geographic impact of Chin‐Tung Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chin‐Tung Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chin‐Tung Chen more than expected).
Fields of papers citing papers by Chin‐Tung Chen
This network shows the impact of papers produced by Chin‐Tung Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chin‐Tung Chen. The network helps show where Chin‐Tung Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Chin‐Tung Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 186 | |
| 2 | 2010 | 147 | |
| 3 | 2008 | 146 | |
| 4 | 2012 | 145 | |
| 5 | 2008 | 97 | |
| 6 | 2016 | 71 | |
| 7 | 2011 | 33 | |
| 8 | 2007 | 27 | |
| 9 | 2004 | 25 | |
| 10 | 2021 | 22 | |
| 11 | 2014 | 21 | |
| 12 | c-MET and HGF mRNA expression in hepatocellular carcinoma: correlation with clinicopathological features and survival. | 2013 | 13 |
| 13 | 2022 | 9 | |
| 14 | 2016 | 9 | |
| 15 | 2021 | 8 | |
| 16 | 2016 | 8 | |
| 17 | 2022 | 6 | |
| 18 | 2022 | 5 | |
| 19 | 2020 | 4 | |
| 20 | 2019 | 3 |
About Chin‐Tung Chen
Chin‐Tung Chen is a scholar working on Oncology, Molecular Biology, Pathology and Forensic Medicine, Cancer Research and Hepatology, having authored 24 papers that have together received 988 indexed citations. Recurring topics across this work include Genetic factors in colorectal cancer (7 papers), Liver physiology and pathology (6 papers), Cancer Genomics and Diagnostics (6 papers), Colorectal Cancer Treatments and Studies (5 papers), Colorectal Cancer Screening and Detection (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers) and Cell Adhesion Molecules Research (2 papers). The work is most often cited by research in Hepatology (250 citations), Oncology (574 citations), Gastroenterology (66 citations), Pathology and Forensic Medicine (184 citations) and Cancer Research (152 citations). Chin‐Tung Chen has collaborated with scholars based in United States, Italy and Germany. Frequent co-authors include Martin R. Weiser, James G. Christensen, David Liska, Thomas Bachleitner‐Hofmann, Philip B. Paty, Zhaoshi Zeng, Mark Gimbel, Sizhi Paul Gao, Todd D. Francone and Mark Y. Sun. Their work appears in journals such as Molecular Cancer Therapeutics, Clinical Cancer Research, Journal of Clinical Oncology, Cancer Research and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.